BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

19410

543213

ROSSARI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ROSSARI BIOTECH LIMITED performance

Today’s low

Today’s high

₹ 654.00 ₹ 690.00
₹ 658.05

52 week low

52 week high

₹ 569.00 ₹ 972.70
₹ 658.05

Open Price

₹ 671.30

Prev. Close

₹ 680.95

Volume (Shares)

93955.00

Total traded value

₹ 618.27

Upper Circuit

₹ 817.10

Lower Circuit

₹ 544.80

info

ROSSARI BIOTECH LIMITED Share Price Update

As of the latest trading session, ROSSARI BIOTECH LIMITED share price is currently at ₹ 655, which is down by ₹ -25.95 from its previous closing. Today, the stock has fluctuated between ₹ 654.00 and ₹ 690.00. Over the past year, ROSSARI BIOTECH LIMITED has achieved a return of -12.73 %. In the last month alone, the return has been 10.55 %. Read More...

ROSSARI BIOTECH LIMITED fundamentals


  • Market cap (Cr)

    3,618.61

  • P/E Ratio (TTM)

    31.82

  • Beta

    0.59

  • Book Value / share

    194.56

  • Return on equity

    10.96%

  • EPS (TTM)

    20.73

  • Dividend yield

    0.08%

  • Net profit/quarter (Cr)

    32.36

info icon alternate text
  • Market cap (Cr)

    3,624.13

  • P/E Ratio (TTM)

    31.82

  • Beta

    0.61

  • Book Value / share

    194.56

  • Return on equity

    10.96%

  • EPS (TTM)

    20.73

  • Dividend yield

    0.08%

  • Net profit/quarter (Cr)

    32.36

info icon alternate text

ROSSARI BIOTECH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 426.65
Operating Expense 385.20
Net Profit 32.36
Net Profit Margin (%) 7.58
Earnings Per Share (EPS) 5.85
EBITDA 54.59
Effective Tax Rate (%) 26.19
Particulars DEC 2024 (Values in Cr)
Revenue 368.28
Operating Expense 328.02
Net Profit 30.63
Net Profit Margin (%) 8.31
Earnings Per Share (EPS) 5.53
EBITDA 50.97
Effective Tax Rate (%) 25.76
Particulars SEP 2024 (Values in Cr)
Revenue 335.99
Operating Expense 300.15
Net Profit 27.42
Net Profit Margin (%) 8.16
Earnings Per Share (EPS) 4.96
EBITDA 45.34
Effective Tax Rate (%) 25.71
Particulars JUN 2024 (Values in Cr)
Revenue 300.71
Operating Expense 269.30
Net Profit 24.33
Net Profit Margin (%) 8.09
Earnings Per Share (EPS) 4.40
EBITDA 41.06
Effective Tax Rate (%) 25.52
Particulars MAR 2024 (Values in Cr)
Revenue 313.80
Operating Expense 280.40
Net Profit 26.17
Net Profit Margin (%) 8.33
Earnings Per Share (EPS) 4.74
EBITDA 43.07
Effective Tax Rate (%) 24.69
Particulars MAR 2025 (Values in Cr)
Revenue 1431.63
Operating Expense 1282.65
Net Profit 114.74
Net Profit Margin (%) 8.01
Earnings Per Share (EPS) 20.75
EBITDA 191.97
Effective Tax Rate (%) 25.83
Particulars MAR 2024 (Values in Cr)
Revenue 1202.91
Operating Expense 1075.55
Net Profit 99.65
Net Profit Margin (%) 8.28
Earnings Per Share (EPS) 18.05
EBITDA 168.01
Effective Tax Rate (%) 25.71
Particulars MAR 2023 (Values in Cr)
Revenue 975.17
Operating Expense 883.13
Net Profit 71.39
Net Profit Margin (%) 7.32
Earnings Per Share (EPS) 12.95
EBITDA 126.25
Effective Tax Rate (%) 25.36
Particulars MAR 2022 (Values in Cr)
Revenue 1072.84
Operating Expense 978.87
Net Profit 79.47
Net Profit Margin (%) 7.40
Earnings Per Share (EPS) 14.49
EBITDA 135.50
Effective Tax Rate (%) 25.50
Particulars MAR 2021 (Values in Cr)
Revenue 690.41
Operating Expense 594.14
Net Profit 79.10
Net Profit Margin (%) 11.45
Earnings Per Share (EPS) 15.34
EBITDA 131.06
Effective Tax Rate (%) 25.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 189.65
ROE % 13.32
ROCE % 18.16
Total Debt to Total Equity 0.10
EBITDA Margin 14.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 165.93
ROE % 12.47
ROCE % 17.52
Total Debt to Total Equity 0.05
EBITDA Margin 13.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 146.25
ROE % 16.10
ROCE % 22.71
Total Debt to Total Equity 0.01
EBITDA Margin 13.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.72
ROE % 23.02
ROCE % 28.71
Total Debt to Total Equity 0.10
EBITDA Margin 18.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 56.48
ROE % 31.79
ROCE % 37.43
Total Debt to Total Equity 0.18
EBITDA Margin 18.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 173.83
ROE % 10.96
ROCE % 14.71
Total Debt to Total Equity 0.07
EBITDA Margin 13.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 155.69
ROE % 8.69
ROCE % 11.72
Total Debt to Total Equity 0.04
EBITDA Margin 12.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 142.50
ROE % 13.37
ROCE % 18.34
Total Debt to Total Equity 0.00
EBITDA Margin 12.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 77.88
ROE % 23.00
ROCE % 28.78
Total Debt to Total Equity 0.10
EBITDA Margin 18.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 55.85
ROE % 32.45
ROCE % 37.97
Total Debt to Total Equity 0.19
EBITDA Margin 18.10
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.21
Total Assets 1572.15
Total Liabilities 1572.15
Total Equity 1047.72
Share Outstanding 55245966
Price to Book Ratio 3.88
Return on Assets (%) 8.31
Return on Capital (%) 11.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 123.93
Total Assets 1367.56
Total Liabilities 1367.56
Total Equity 915.16
Share Outstanding 55155486
Price to Book Ratio 3.82
Return on Assets (%) 7.84
Return on Capital (%) 10.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.35
Total Assets 1256.72
Total Liabilities 1256.72
Total Equity 805.16
Share Outstanding 55056386
Price to Book Ratio 6.41
Return on Assets (%) 7.77
Return on Capital (%) 12.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.26
Total Assets 561.34
Total Liabilities 561.34
Total Equity 408.77
Share Outstanding 51929390
Price to Book Ratio 13.32
Return on Assets (%) 14.29
Return on Capital (%) 19.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 127.23
Total Assets 471.51
Total Liabilities 471.51
Total Equity 286.67
Share Outstanding 50752920
Price to Book Ratio 0.00
Return on Assets (%) 13.83
Return on Capital (%) 18.77
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.67
Total Assets 1281.16
Total Liabilities 1281.16
Total Equity 960.34
Share Outstanding 55245966
Price to Book Ratio 3.88
Return on Assets (%) 7.77
Return on Capital (%) 9.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.27
Total Assets 1125.66
Total Liabilities 1125.66
Total Equity 858.69
Share Outstanding 55155486
Price to Book Ratio 3.82
Return on Assets (%) 6.34
Return on Capital (%) 7.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.81
Total Assets 925.93
Total Liabilities 925.93
Total Equity 784.52
Share Outstanding 55056386
Price to Book Ratio 6.41
Return on Assets (%) 8.58
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 85.98
Total Assets 544.35
Total Liabilities 544.35
Total Equity 404.44
Share Outstanding 51929390
Price to Book Ratio 13.32
Return on Assets (%) 14.53
Return on Capital (%) 19.56
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 127.20
Total Assets 468.28
Total Liabilities 468.28
Total Equity 283.47
Share Outstanding 50752920
Price to Book Ratio 0.00
Return on Assets (%) 13.99
Return on Capital (%) 19.02
Particulars MAR 2024 (Values in Cr)
Net Income 177.61
Cash from Operations 97.13
Cash from Investing -103.21
Cash from Financing 16.18
Net change in Cash -43.77
Free Cash Flow 228.41
Particulars MAR 2023 (Values in Cr)
Net Income 144.21
Cash from Operations 199.33
Cash from Investing -180.89
Cash from Financing 60.85
Net change in Cash 31.51
Free Cash Flow 232.21
Particulars MAR 2022 (Values in Cr)
Net Income 136.27
Cash from Operations 79.48
Cash from Investing -298.87
Cash from Financing 291.79
Net change in Cash 22.26
Free Cash Flow 117.70
Particulars MAR 2021 (Values in Cr)
Net Income 106.83
Cash from Operations 79.11
Cash from Investing -37.17
Cash from Financing -24.59
Net change in Cash -14.00
Free Cash Flow 137.19
Particulars MAR 2020 (Values in Cr)
Net Income 88.05
Cash from Operations 76.97
Cash from Investing -190.30
Cash from Financing 156.94
Net change in Cash 23.47
Free Cash Flow 152.94
Particulars MAR 2024 (Values in Cr)
Net Income 134.13
Cash from Operations 109.41
Cash from Investing -69.54
Cash from Financing -22.09
Net change in Cash -17.72
Free Cash Flow 161.24
Particulars MAR 2023 (Values in Cr)
Net Income 95.64
Cash from Operations 137.94
Cash from Investing -160.58
Cash from Financing 61.20
Net change in Cash 13.55
Free Cash Flow 159.40
Particulars MAR 2022 (Values in Cr)
Net Income 106.68
Cash from Operations 57.34
Cash from Investing -318.11
Cash from Financing 296.91
Net change in Cash 11.91
Free Cash Flow 89.79
Particulars MAR 2021 (Values in Cr)
Net Income 105.99
Cash from Operations 83.02
Cash from Investing -36.99
Cash from Financing -29.45
Net change in Cash -14.36
Free Cash Flow 141.00
Particulars MAR 2020 (Values in Cr)
Net Income 88.10
Cash from Operations 75.89
Cash from Investing -187.24
Cash from Financing 154.96
Net change in Cash 23.46
Free Cash Flow 151.86
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6752.85 41.08 3.55 19881.58 4882.00 / 8165.25
BASF INDIA LTD 4475.60 32.11 5.52 19372.92 3715.95 / 8748.10
ORIENTAL AROMATICS LTD 345.15 27.01 1.76 1161.55 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1301.35 18.86 2.89 16427.96 500.85 / 1443.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 171.00 58.56 4.19 15.39 168.50 / 330.00
ATUL LTD 6752.85 43.57 3.58 19881.58 4882.00 / 8165.25
BASF INDIA LTD 4475.60 32.10 5.52 19372.92 3715.95 / 8748.10
ORIENTAL AROMATICS LTD 345.15 23.77 1.75 1161.55 252.40 / 656.00

ROSSARI BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
658.05 -3.36 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 679.50
  • 26 Days 666.20
  • 10 Days 680.40
  • 50 Days 669.80
  • 12 Days 678.40
  • 100 Days 701.20
  • 20 Days 670.00
  • 200 Days 740.10
685.18 PIVOT

First Support

670.77

First Resistance

695.37

Second Support

660.58

Second Resistance

709.78

Third Support

646.17

Third Resistance

719.97

RSI

56.10

ADX

25.90

MACD

15.35

Williams % R

-27.06

Commodity Channel Index (CCI)

50.38

Date

2025-04-28

Week

127840.00

Same Day

36852.00

Month

68389.00

1 Year

0.60

3 Year

0.62

Over 1 Month

10.55%

down

Over 1 Year

-12.73%

down

Over 3 Months

-4.94%

down

Over 3 Years

-10.48%

down

Over 6 Months

-11.82%

down

Over 5 Years

-1.69%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ROSSARI BIOTECH LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
10.24%
Promoter Holdings
68.17%
FII
3.98%
DII
17.59%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Edward Menezes 1.611882E7 (29.11%) Shareholding of Promoter and Promoter Group
Sunil Srinivasan Chari 1.608932E7 (29.06%) Shareholding of Promoter and Promoter Group
Rossari Biotech (india) Private Limited 3016200.0 (5.45%) Shareholding of Promoter and Promoter Group
Sbi Small Cap Fund 2916342.0 (5.27%) Public Shareholding
Uti-flexi Cap Fund 2245189.0 (4.06%) Public Shareholding
Life Insurance Corporation Of India 2219115.0 (4.01%) Public Shareholding
Motilal Oswal Small Cap Fund 1128365.0 (2.04%) Public Shareholding
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund 1067293.0 (1.93%) Public Shareholding
Jyotishna Sunil Chari 1000330.0 (1.81%) Shareholding of Promoter and Promoter Group
Anita Menezes 1002630.0 (1.81%) Shareholding of Promoter and Promoter Group
Yash Sunil Chari 165000.0 (0.3%) Shareholding of Promoter and Promoter Group
Mikhail Menezes 133200.0 (0.24%) Shareholding of Promoter and Promoter Group
Chari Family Trust - In The Name Of Sunil Srinivasan Chari 110000.0 (0.2%) Shareholding of Promoter and Promoter Group
Menezes Family Trust - In The Name Of Edward Walter Menezes 110000.0 (0.2%) Shareholding of Promoter and Promoter Group
Yashika Chari 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ronald Dcunha 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sunjyot Properties Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Glad Properties (india) Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Suisse Silicon Specialties Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rossari Manuchar (india) Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sunil Chari (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Neera Gupta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Priyata Chopra 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Geeta Gupta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Manish Mehta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chanderkanta Mehta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Satish Mehta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Malini Nainani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Priya Shivdasani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Charlotte Dmello 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Stella Dcunha 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Yvette Santhmayor 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Henry Menezes 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ROSSARI BIOTECH LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 May 2023 0.5 Final 24 May 2023 Equity shares
07 Jul 2022 0.5 Final 08 Jul 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 May 2023 0.5 Final 24 May 2023 Equity shares
07 Jul 2022 0.5 Final 08 Jul 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ROSSARI BIOTECH LIMITED Share Price

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry. It was further renamed to Rossari Biotech Limited and converted into a company in 2009. The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products.

During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each. Accordingly 4,400,000 paid-up equity shares of face value of Rs 10 each was split into 22,000,000 Equity Shares of face value of Rs 2 each.

The Company has issued and allotted 2,64,00,000 Equity Shares of face value of Rs 2/- each to the eligible Members of the Company in the ratio of 6(Six) Equity share for every 5 (Five) Equity shares, as Bonus Equity shares.

During the year 2019-20, in compliance with the provisions of Sections 42 & 62 of the Act and Rules made thereunder, the Company has issued and allotted 23,52,920 Equity Shares of face value of Rs 2/- each to the eligible Qualified Institutional Buyers at issue price of Rs 425/- per Equity Share i.e. at a premium of Rs 423/- per Equity Share aggregating to Rs 99,99,91,000 /-on preferential basis through private placement.

During the second quarter of FY2021,the Company has completed Initial Public Offer (IPO) of 11,676,470 Equity Shares of the face value of Rs. 2/- each at an issue price of Rs. 425/- per Equity Share, comprising offer for sale of 10,500,000 shares by Selling Shareholders and fresh issue of 1,176,470 shares. The Equity Shares of the Company were listed on 23 July 2020 on Bombay Stock Exchange and National Stock Exchange of India Limited.

The Company has a wholly owned subsidiary, Rossari Personal Care Products Private Limited (Formerly known as Neutron Impex Private Limited) which was engaged in the business of manufacturing, exporting and importing specialty chemicals, dyes, etc. upto 31 March 2015. The Company has also acquired a Joint Venture (JV) company, Buzil Rossari Private Limited, engaged in the business of providing Trading of specialty chemicals. Buzil Rossari Private Limited ('BRPL') became a wholly owned subsidiary of the Company w.e.f. 31 August 2020.

During the year ended on 31 March, 2021, the Board of Directors at its meeting held on 23 March, 2021, has approved the issue of 3,012,046 equity shares on preferential basis for cash consideration . Subsequent to year ended 31March, 2021, the shareholders of the Company at its Extra Ordinary General meeting held on 17April, 2021 has approved issue of 3,012,046 shares of face value of Rs. 2 each on preferential basis at price of Rs. 996 per share aggregating to Rs. 3000.00 million. The allotment of the shares of the Company has been completed on 21April, 2021.

Pursuant to the lockdowns by the central and state government authorities to contain the spread of COVID-19 outbreak, the Company's operations and financial results for the year have been impacted. The operations gradually resumed in a phased manner with requisite precautions during the year ended 31 March, 2021. Company achieved the full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat on 31st March, 2021.

During the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 02 June, 2021 has agreed to acquire 100% of shareholding of Unitop Chemicals Private Limited at an aggregate consideration of Rs. 4,210 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.

Also Subsequent to the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 17 July, 2021 has agreed to acquire 100% shareholding of Tristar Intermediates Private Limited at an aggregate consideration of Rs. 1,200.00 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.

Further, subsequent to quarter ended 30 June, 2021, the Company at its meeting of the Board of Directors held on 30 July 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paid-up share capital of Romakk Chemicals Private Limited ('Romakk') at an aggregate consideration of Rs. 75.10 million.

Subsequent to the quarter ended 30 June 2021, the Company has acquired balance 40% stake in its subsidiary Rossari Personal Care Products Private Limited for aggregate consideration of Rs. 20.00 million making it a wholly owned subsidiary of the Company.

Solar Panel was Installed at Dahej Plant to accommodate 1 MW Solar Power Installation in FY'22. Total Energy Savings in FY21-22 was 50 KVA. During the Financial Year 2021-22, the Company announced strategic acquisitions of three high-quality and high potential companies in the Speciality Chemical space viz. Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, and Romakk Chemicals Private Limited. Strategic investment in Unitop Chemicals, Tristar Intermediates and Romakk Chemicals unlocked significant cross selling opportunities. A new line of products based on polyester chemistry was developed and ramped up at Rossari's Dahej facility, addressing a key product gap in textile portfolio for the sizing of market in polyester and cotton fabric. R&D introduced green products in newer divisions to reduce high TDS and save energy by designing products that work at lower temperatures. The Sustainable dyeing', programmed for blacks, using Green Chemistry, has been successful on knit fabric and is generating good interest from big brands.

During 2021-22, the Company acquired a controlling stake in Unitop Chemicals. It acquired Tristar Intermediates, aroma chemicals, and home and personal care additives with high-tech distillation facilities. It completed the integration of Romakk Chemicals during FY'22, acquiring a 50.1% stake in the company.

During FY 2022-23, the Company acquired additional stake of 15% in Unitop Chemicals Pvt Ltd (UCPL) and 8% in Tristar Intermediates Pvt Ltd., taking the Company's holding to 80% and 84%, respectively. Also, the Company has acquired the remaining 16% stake in TIPL after the end of the Financial Year 2022-23.

Parent organization Indian Private
NSE symbol ROSSARI
Founded 2009
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Rossari Biotech Ltd?

Answer Field

The share price of Rossari Biotech Ltd for NSE is ₹ 655 and for BSE is ₹ 656.

What is the Market Cap of Rossari Biotech Ltd?

Answer Field

The market cap of Rossari Biotech Ltd for NSE is ₹ 36,18.61 Cr. and for BSE is ₹ 36,24.13 Cr. as of now.

What is the 52 Week High and Low of Rossari Biotech Ltd?

Answer Field

The 52 Week High and Low of Rossari Biotech Ltd for NSE is ₹ 972.70 and ₹ 569.00 and for BSE is ₹ 966.00 and ₹ 568.05.

How to Buy Rossari Biotech Ltd share?

Answer Field

You can trade in Rossari Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Rossari Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -12.17%.

What is the Current Share Price of Rossari Biotech Ltd?

Answer Field

Rossari Biotech Ltd share price is for NSE ₹ 655 & for BSE ₹ 656 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Rossari Biotech Ltd Share?

Answer Field

The market cap of Rossari Biotech Ltd for NSE ₹ 36,18.61 & for BSE ₹ 36,24.13 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Rossari Biotech Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Rossari Biotech Ltd share is 31.82.

What is the PB ratio of Rossari Biotech Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Rossari Biotech Ltd share is 194.56.

How to Buy Rossari Biotech Ltd Share?

Answer Field

You can trade in Rossari Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rossari Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Rossari Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rossari Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|